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Batten disease, or the juvenile form of neu­
ronal ceroid lipofuscinosis, is an autosomal 
recessive neurodegenerative disorder m ani­
festing with progressive blindness, seizures, 
and dementia, leading to an early death. The 
CLN3 locus w hich is involved in Batten dis­
ease had been localized to chromosome 
16pll.2. Linkage disequilibrium  has been  
observed betw een CLN3 and polymorphic 
m icrosatellite markers D16S288, D16S299, 
and D16S298, m aking carrier detection and 
prenatal diagnosis by haplotype analysis 
possible. For the purpose of carrier detec­
tion, haplotypes from Dutch Batten patients 
and their fam ilies w ere constructed. Most 
patients share the sam e D16S298 allele, sug- 
gesting the presence of a founder effect in 
the Dutch population. In a large inbred 
Dutch family, in w hich Batten disease oc­
curs with high frequency, haplotype analy­
sis has been carried out with high accuracy 
for carrier detection. © 1905 Wiley-1 jisH, Inc.
KEY WORDS: Batten disease, carrier detec
tion, haplotype analysis
INTRODUCTION
Batten disease is an autosomal recessive neuro­
degenerative disorder belonging to the neuronal ceroid 
lipofuscinoses (NCL), which are characterized by the 
intracellular accumulation of autofluorescent lipopig- 
ments. On the basis of the age at onset, the clinical
Received for publication July 1, 1994; no revimonn.
AddroHH reprint requests to Pete)’ 13,M. Tn neb ner, Department 
of Genetic«, Section of Human Genetic«, Sylvius Laboratorio«, 
Leiclen University, P.O. Box 9503, 2300 RA Leiden, The Nether­
lands.
manifestations, and the distinct patterns formed by 
accumulated lipopigments, four major types can be 
distinguished; infantile NCL or ITaltia-Santavuori dis­
ease (MIM 256730), late infantile NCL or Jansky- 
Bielschowsky disease (MIM 204500), juvenile NCL or 
Batten (Spielmeyer-Vogt) disease (MIM 204200), and 
adult NCL or Kufs disease (MIM 204300). Batten pa­
tients develop progressive blindness, seizures, and 
dementia, leading to an early death. The clinical diag­
nosis is confirmed by the presence of fingerprint pat­
terns on ultrastructural examination of different tis­
sues [Brod et aL, 1987.1. The biochemical defect causing 
Batten disease still remains unknown.
Linkage of Batten disease locus CLN3 to chromo­
some 16 was established by Eiherg et al. [1989]. Subse­
quent linkage analysis placed CLN3 on 16pl2 in an 8 
cM interval between D16S297 and D16S57 [Mitchison 
et al., 1993']. CLN3 was observed to be in strong link­
age disequilibrium with alleles of the microsatellites
D16S288, D16S299, and D16S298. Recently, the map 
position of CLN3 was refined by recombination to a 2.1 
cM interval between I3I6S288 and D16S383 IMitehison 
et al, 1994).
The presence of flanking polymorphic markers 
closely linked to the CLN3 gene makes carrier detec­
tion, presymptomatic diagnosis* and prenatal diagnosis 
feasible. The frequency of occurrence of Batten disease 
in the Netherlands is estimated to be 1 in 100,000. In 
Zeeland (South West Netherlands) clustering of Batten 
disease occurs in a large inbred family from an isolated 
Catholic enclave in a predominantly Protestant area. 
The family is aware of the increased risk for Batten dis­
ease. As a consequence, relatives frequently seek 
genetic counselling. Here, we report the results of car­
rier detection in this large inbred family.
MATERIAL AND METHODS
Family M aterial
total of 25 Dutch families participated in this 
, in which 33 Batten patients and 208 r Mi
© 1995 Wiley-Liss, Inc.
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Fig. 1. The CLN3 interval on chromosome 16. The breakpoints of hybrid cell lines containing parts of 
chromosome 16 are indicated on the left. Arrows point towards the retained part of chromosome 16. 
Adapted from Hildebrand et al. [1993],
were analyzed. The large inbred family used in the cur­
rent study has been presented previously [Pinckers and 
Hoppe, 1978; Pinckers, 1983]* Pedigrees were traced 
back for at least 5 generations to discover possible rela­
tionships. Where possible, grandparents were included 
for the construction of unambiguous haplotypes.
The diagnosis of Batten disease was established ac­
cording to the criteria described [Rapola, 1993]. The 
clinical diagnosis was considered to be confirmed when 
characteristic fingerprint patterns were observed in 
lymphocyte inclusion bodies by electron microscopy.
PCR Analysis
Genomic DNA was prepared from peripheral blood 
samples or from EBV-transformed lymphocyte cell 
lines by standard procedures [Breuning et al., 1990].
Polymorphic microsatellite markers D16S295, 
D16S296, D16S297, D16S288, D16S299, D16S298, 
D16S383, SPN [using new primers described by Mitchi- 
son et al. 1994], D16S300, D16S261, and D16S304 were 
used for haplotype construction [Reeders et al., 1991; 
Thompson et al., 1992; Hildebrand et al., 1993; Rogaev 
and Keryanov, 1992; Shen et al., 1991]. PCR was car-
TABLE I. Haplotype Frequencies on Batten Chromosomes in the Dutch Population
Markers Number of haplotypes
-- ----- > > i
D16S288 D16S299 D16S298
From independent 
Batten patients
Deduced from parents of 
deceased Batten patients
7 5 6 23 10
4 5 6 6 0
8 5 6 6 0
5 5 6 3 1
5 6 6 2 1
3 6 4 4 1
Others 6 1
Total 50 14
ried out on 50 ng genomic DNA in a total volume of 
15 p i at a final concentration of 50 mM KC1; 1.5 mM 
MgCl2; 200 pM  each of dATP, dGTP, dTTP; 0.004 U /pl of 
SuperTaq (HT Biotechnology Ltd., Cambridge, UK), in 
the presence of a-,i2P-dCTP and 6 pmol of each primer. 
Denaturation was 3 m m  at 94°C, followed by 27 cycles 
of amplification with denaturation for 1 min at 94°C, 
annealing for 2 min at 50°C (D16S297, D16S383, 
D16S300, D16S261, and D16S304), 55°C (D16S295, 
D16S296, D16S299, D16S298, and SPN), or 60°C 
(D16S288), and extension for 1 min at 72°C, with a final 
extension for 10 min. Twenty microliters of loading 
buffer was added to the samples before electrophoresis 
on a 6% denaturing polyacrylamide gel. The gel was 
autoradiographed for 20 h at -~7G°C with Kodak XAR5 
film.
Risk Calculation
Risk calculations were performed as described by 
Young [1991], For the sake of simplicity, risk calcula­
tions have been performed assuming single consan­
guineous relationships between the parents*
RESULTS
Allelic A ssociation
Iiaplotypes from families with Batten patients were 
constructed using the markers shown in Figure 1. Al­
lelic association of markers D16S288, D16S299, and 
D16S298 with the CLN3 locus is also found in the 
Dutch population (Table I). The D16S288-D16S299- 
D16S298 haplotype “7 5 6” is found on 23 chromosomes 
from 25 Batten patients tested. In addition, this haplo­
type was found on 10 out of 14 chromosomes from par­
ents of deceased Batten patients. The “4 5 6,” <c8 5 6,” 
and “5 5 6” haplotypes found on 16 chromosomes may 
be derived from the “7 5 6” haplotype by recombination 
between D16S288 and D16S299. Recombination be­
tween D16S299 and D16S298 may have resulted in the 
other haplotypes containing D16S298 allele 6 observed 
on 9 CLN3 chromosomes. Two independent patients 
are homozygous for D16S298 allele 4. The strong asso­
ciation of the CLN3 mutation with D16S298 allele 6 in 
almost all Dutch patients suggests that they share a 
single ancestral mutation. Only 6 out of 64 CLN3 chro­
mosomes carry a different D16S298 allele, suggesting 
that about 9.4% of the Dutch CLN3 chromosomes con­
tain a different mutation. The frequency of other CLN3 
mutations in the Dutch population is estimated to be 
0.03% (9.4% of the total CLN3 mutation frequency).
Carrier D etection
The linkage disequilibrium between CLN3 and the 
markers D16S288, D16S299, and D16S298 which is ob­
served in the Dutch population can be used for carrier 
detection. In a large inbred family from Zeeland, 17 
Batten patients are known of whom 7 have been ana­
lyzed (NCL 1.2, 1.3, 1.4, 1.5, 1.15, 1.16, 1.17 in Fig. 2),
Fig. 2. Pcdigreoof a 1 arge i11brecl family from Zae 1«ncl, in wh icli B aC- 
ten disease occurs with relatively high frequency. The consanguineous 
couple NCL 1.47 and NCL 1.4-8 hen boon seeking genetic counselling for 
Batten disease. Individual haplotypeH are shown for the chromosome 16 
markers listed on the left, next to NCL 1.62. Individual» appearing 
twice are indicated by A-H. Squares, circles, and diamonds: males, fe­
males, and sex not shown to protect privacy. Black, black and white, 
and white symbols: a flee teds, carriers, una flee teds. Slash through sym­
bol: deceased. Black bars, chromosomes carrying the CLN3 mutation.
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TABLE II. Risk Calculations
A) Calculation of prior carrier risk for NCL l,47u
Carrier status
Both NCL 1.49 
and NCL 1.50
are carriers
Only NCL 1.49
is a carrier
Only NCL 1.50 
is a carrier
Neither NCL 1.49 
nor NCL 1.50 
are carriers Total risk
Probability 
Prior risk for NCL 
1.47 to be—
1/2 X 1/32 - 1.6% 1/2 X 31/32 - 48.4% 1/2 X 1/32 - 1.6% 1/2 X 31/32 = 48.4%
Affected 1/4 X 1/2 X 1/32 0 0 0 0.4%
Carrier 1/2 x 1/2 X 1/32 1/2 X 1/2 X 31/32 1/2 x 1/2 X 1/32 0 25,8%
No carrier 1/4 X 1/2 X 1/32 1/2 X 1/2 X 31/32 1/2 X 1/2 X 1/32 1/2 X 31/32 73.8%
B) Prior risk calculation for offspring from NCL 1.4-7 and NCL 1.48'
Carrier status
* VI ■— V -•«
Both NCL 1.47 
and NCL 1.48
are carriers NCL 1.47 or NCL 1.48 is a carrier
Neither NCL 1.47 
nor NCL 1.48 
are carriers Total risk
—n -'c ‘V"’* pv* '
Probability
Prior risk for offspring to be 
Affected 
Carrier 
N o carrier
( 66/255)2 = 6.7% 2 X (66/255) X (189/255) = 38.4% (189/255 )a = 54,9%
1/4 X (66/255)a 
1/2 X (66/255)a 
1/4 X (66/255?
0
(66/255) x (1.89/255) 
(66/256) x (189/255)
0
0
(189/255)2
1.7%
22.5%
75.8%
“Risk calculations for NCL 1.48 have the same results.
l)The carrier probability of 66/255 for NCL 1.47 and NCL 1.48 was derived by dividing the total carrier probability (66/256) by the sum of the 
total probabilities of being carrier and being no carrier (66/256 + 189/256), since the possibility that NCL 1.47 and NCL 1.48 are affected can 
be excluded.
All carried the D16S288-D16S299-D16S298 haplotype 
“8 5 6 .” Iiaplotype analysis of parents of deceased pa­
tients suggests that only two patients carried a differ­
ent haplotype which was inherited from the parent who 
was not related to the family (NCL 1.62 in Fig. 2),
Members from this family are aware of the increased 
risk for Batten disease. The couple NCL 1.47 and NCL 
1.4-8, who are related, have asked for genetic advice 
concerning Batten disease (see Fig. 2). NCL 1.47 and 
NCL 1*4-8 have 4- and 2 cousins suffering from Batten 
disease, respectively. All parents of NCL 1,47 and NCL 
L48 are related, To simplify the risk calculations, sin­
gle relationships have been assumed between the par­
ents. Parents NCL 1.49 and NCL 1.53, as siblings of 
obligate carriers, have a prior carrier probability of at 
least 50%. Parents NCL 1.50 and NCL 1.54 as second 
cousins of obligate carriers have a prior carrier proba­
bility of at least 3.1% (1/32). These values can be used 
to calculate the prior carrier risk for their children
(Table IIA). The fact that NCL 1.47 and NCL 1.48 are 
not affected results in a carrier risk of 25.9% (66/255). 
Therefore, couple NCL 1.47 and NCL 1.48 have a prior 
risk of 1.7% for an affected child, of 22.5%; for a child 
being a carrier, and of 75.8% for a child who does not 
inherit the CLN3 mutation (see Table IIB).
Haplotype analysis shows that only father NCL 1.49 
of NCL 1.47 is a carrier of the “8 5 6” haplotype. Mother 
NCL 1.54 of NCL 1.48 carries on one of her chromo­
somes the ic6 6 6” haplotype, which may have arisen by 
recombination of the “8 5 6” haplotype. NCL 1.47 did 
not inherit the “8 5 6” haplotype from father NCL 1.49 
and NCL 1.48 did not inherit the “6 6 6” haplotype from
mother NCL 1.54, Since the probability of a second un­
related carrier haplotype in this family is estimated to 
be very low (0.03 %), the risk of being a carrier for NCL 
1.47 and NCL 1.48 is virtually reduced to the probabil­
ity of an undetectable double recombination event be­
tween the markers flanking CLN3. Since the largest 
distance between two markers within the CLN3 inter­
val is 0.9 cM, the probability of an undetectable double 
recombination event between two markers (0.0081%) 
can be neglected. By contrast, sibling NCL 1.52, who 
had the same prior carrier risk as NCL 1.47, has inher­
ited the “8 6 6” high risk haplotype from father NCL
1,49, Therefore, the probability of NCL 1.52 not being a 
carrier is practically reduced to zero,
DISCUSSION
Diagnosis of Batten disease is based on the clinical 
manifestations and the electron microscopic observa­
tion of fingerprint patterns formed by accumulating 
lipopigments in different tissues. In carriers, no finger­
print patterns can be observed. Therefore, carrier de­
tection for Batten disease has not been possible.
Here, we demonstrate that the recently found allelic 
association between the CLN3 mutation and polymor­
phic markers D16S288, D16S299, and D16S298 can be
used to offer reliable carrier detection to sibs and to 
more distant relatives of Batten patients. Carrier 
detection in more distant relatives is less reliable, due 
to the increased possibility of recombination. Unfortu­
nately, the allelic association observed between CLN3 
and D16S299 or D16S298 is not sufficiently strong to be 
used for carrier detection among unrelated partners of
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known carriers. Although observation of the “7 5 6” 
high risk haplotype in a partner would strongly suggest 
that this person is a carrier, the absence of this or of a 
derived haplotype cannot exclude the carrier status 
with certainty due to limited information about haplo­
type frequencies in the Dutch population.
Previously, prenatal diagnosis of Batten disease was 
performed by electron microscopical screening of chorion 
villi and fetal tissues for fingerprint patterns [Conradi et 
al., 1989; Kohlschtitter et al., 1989 b Unfortunately, the 
absence of fingerprints in chorion villi or fetal tissue can­
not be considered as conclusive evidence of the absence 
of Batten disease. DNA-based prenatal diagnosis gives 
more conclusive evidence; the fetus is affected, carrier or 
non-carrier depending on its haplotypes. Reliable pre­
natal diagnosis is possible for new pregnancies of oblig­
ate carriers and in consanguineous marriages in the 
Zeeland cluster of families, when both partners have 
been identified as carriers by haplotype analysis.
The observed allelic association suggests that the 
CLN3 gene is in close vicinity of markers D16S299 and 
D16S298. Isolation of cDNAs from this region is ex­
pected to lead to the isolation of the CLN3 gene, which 
will allow direct mutation analysis and more reliable 
counselling in the near future.
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